Your browser doesn't support javascript.
loading
Comparative effectiveness of glatiramer acetate and interferon beta formulations in relapsing-remitting multiple sclerosis.
Kalincik, Tomas; Jokubaitis, Vilija; Izquierdo, Guillermo; Duquette, Pierre; Girard, Marc; Grammond, Pierre; Lugaresi, Alessandra; Oreja-Guevara, Celia; Bergamaschi, Roberto; Hupperts, Raymond; Grand'Maison, Francois; Pucci, Eugenio; Van Pesch, Vincent; Boz, Cavit; Iuliano, Gerardo; Fernandez-Bolanos, Ricardo; Flechter, Shlomo; Spitaleri, Daniele; Cristiano, Edgardo; Verheul, Freek; Lechner-Scott, Jeannette; Amato, Maria Pia; Cabrera-Gomez, Jose Antonio; Saladino, Maria Laura; Slee, Mark; Moore, Fraser; Gray, Orla; Paine, Mark; Barnett, Michael; Havrdova, Eva; Horakova, Dana; Spelman, Timothy; Trojano, Maria; Butzkueven, Helmut.
Afiliación
  • Kalincik T; Department of Medicine, University of Melbourne, Melbourne, Australia and Department of Neurology, Royal Melbourne Hospital, Melbourne, Australia tomas.kalincik@unimelb.edu.au.
  • Jokubaitis V; Department of Medicine, University of Melbourne, Melbourne, Australia and Department of Neurology, Royal Melbourne Hospital, Melbourne, Australia.
  • Izquierdo G; Hospital Universitario Virgen Macarena, Sevilla, Spain.
  • Duquette P; Hôpital Notre Dame, Montreal, Canada.
  • Girard M; Hôpital Notre Dame, Montreal, Canada.
  • Grammond P; Hotel-Dieu de Levis, Quebec, Canada.
  • Lugaresi A; MS Center, Neuroscience, Imaging and Clinical Sciences, University 'G. d'Annunzio', Chieti, Italy.
  • Oreja-Guevara C; University Hospital San Carlos, IdISSC, Madrid, Spain.
  • Bergamaschi R; National Neurological Institute C. Mondino, Pavia, Italy.
  • Hupperts R; Orbis Medical Center, Sittard, the Netherlands.
  • Grand'Maison F; Neuro Rive-Sud, Hôpital Charles LeMoyne, Quebec, Canada.
  • Pucci E; Ospedale di Macerata, Macerata, Italy.
  • Van Pesch V; Cliniques Universitaires Saint-Luc, Brussels, Belgium.
  • Boz C; Karadeniz Technical University, Trabzon, Turkey.
  • Iuliano G; Ospedali Riuniti di Salerno, Salerno, Italy.
  • Fernandez-Bolanos R; Hospital Universitario Virgen de Valme, Seville, Spain.
  • Flechter S; Assaf Harofeh Medical Center, Beer-Yaakov, Israel.
  • Spitaleri D; AORN San Giuseppe Moscati, Avellino, Italy.
  • Cristiano E; Hospital Italiano, Buenos Aires, Argentina.
  • Verheul F; Groen Hart Ziekenhuis, Gouda, the Netherlands.
  • Lechner-Scott J; John Hunter Hospital, Newcastle, Australia.
  • Amato MP; Department NEUROFARBA, Section of Neurosciences, University of Florence, Florence, Italy.
  • Cabrera-Gomez JA; Centro Internacional de Restauracion Neurologica, Havana, Cuba.
  • Saladino ML; INEBA, Buenos Aires, Argentina.
  • Slee M; Flinders University and Medical Centre, Adelaide, Australia.
  • Moore F; Jewish General Hospital, Montreal, Canada.
  • Gray O; Craigavon Area Hospital, Portadown, UK.
  • Paine M; St Vincent's Hospital, Melbourne, Australia.
  • Barnett M; Brain and Mind Research Institute, Sydney, Australia.
  • Havrdova E; Department of Neurology and Center of Clinical Neuroscience, 1st Faculty of Medicine, General University Hospital and Charles University in Prague, Czech Republic.
  • Horakova D; Department of Neurology and Center of Clinical Neuroscience, 1st Faculty of Medicine, General University Hospital and Charles University in Prague, Czech Republic.
  • Spelman T; Department of Medicine, University of Melbourne, Melbourne, Australia and Department of Neurology, Royal Melbourne Hospital, Melbourne, Australia.
  • Trojano M; Department of Basic Medical Sciences, Neuroscience and Sense Organs, University of Bari, Bari, Italy/These authors contributed equally to the manuscript.
  • Butzkueven H; Department of Medicine, University of Melbourne, Melbourne, Australia, Department of Neurology, Royal Melbourne Hospital, Melbourne, Australia, and Department of Neurology, Box Hill Hospital, Monash University, Box Hill, Australia.
Mult Scler ; 21(9): 1159-71, 2015 Aug.
Article en En | MEDLINE | ID: mdl-25480857

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Interferón beta / Esclerosis Múltiple Recurrente-Remitente / Acetato de Glatiramer / Factores Inmunológicos Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Mult Scler Asunto de la revista: NEUROLOGIA Año: 2015 Tipo del documento: Article País de afiliación: Australia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Interferón beta / Esclerosis Múltiple Recurrente-Remitente / Acetato de Glatiramer / Factores Inmunológicos Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Mult Scler Asunto de la revista: NEUROLOGIA Año: 2015 Tipo del documento: Article País de afiliación: Australia
...